公开(公告)号：US12233100B1

公开(公告)日：2025-02-25

申请号：US18932631

申请日：2024-10-31

Applicant: Tae Yoon Kim

Inventor： Tae Yoon Kim

IPC: A61K31/00 ,  A61K31/19 ,  A61K31/194 ,  A61K31/20 ,  A61K31/202 ,  A61K31/365 ,  A61K31/728 ,  A61K33/04 ,  A61K33/30 ,  A61K35/614 ,  A61K35/644 ,  A61K35/748 ,  A61K36/05 ,  A61K36/185 ,  A61K36/22 ,  A61K36/258 ,  A61K36/288 ,  A61K36/31 ,  A61K36/346 ,  A61K36/48 ,  A61K36/55 ,  A61K36/68 ,  A61K36/78 ,  A61K36/81 ,  A61K36/899 ,  A61K36/8998 ,  A61K38/06 ,  A61K38/16

Abstract: A composition for improving respiratory health of companion animals, includes butyric acid as a short-chain fatty acid, propionic acid as a short-chain fatty acid, acetic acid as a short-chain fatty acid, red ginseng extract powder, Siberian gooseberry extract powder, omega-3 fatty acid, glutathione powder, chlorella powder, spirulina powder, propolis powder, plantago seed (psyllium) husk powder, zinc powder and CTF-901 as active ingredients, thereby inhibiting bronchial thickening in airway smooth muscle cells through edible feeding thus to contribute to enhancement of respiratory health.

公开(公告)号：US20240245746A1

公开(公告)日：2024-07-25

申请号：US18518451

申请日：2023-11-23

Applicant: TCI CO., LTD.

Inventor： YUNG-HSIANG LIN ,  Pei-Han CHANG CHIEN

IPC: A61K36/8998 ,  A61P11/14 ,  A61P25/04 ,  A61P29/00

CPC classification number: A61K36/8998 ,  A61P11/14 ,  A61P25/04 ,  A61P29/00 ,  A61K2236/19

Abstract: A method for regulating immunity is provided. The method includes administering to a subject in need thereof a composition that includes an effective dose of black hulless barley extract. The black hulless barley extract is obtained by extracting seeds of black hulless barley (Hordeum vulgare L. var. nudum Hook. f.) with an amylase aqueous solution.

公开(公告)号：US11622987B2

公开(公告)日：2023-04-11

申请号：US16590807

申请日：2019-10-02

Applicant: Eir Pharmaceuticals, LLC

Inventor： William P. Duncan ,  Lauren S. Gollahon ,  William C. Putnam

IPC: A61K36/00 ,  A61K36/54 ,  A61K9/00 ,  A61K36/28 ,  A61K36/53 ,  A61K36/254 ,  A61K36/31 ,  A61K36/481 ,  A61K36/8998 ,  A61K36/355

Abstract: The preparation of an aqueous extract resulting from an aqueous extraction process of Cinnamomum aromaticum, Arctium lappa, Viticis fructus, Lonicera japonica, Acanthopanax gracilistylis, Raphanus sativus, Astragalus membranaceus and Hordeum vulgare and the chemical composition comprising said extract or fraction thereof, and the use of said composition or fraction thereof for treating or preventing cancers and inflammation related diseases, hair loss, stimulating hair growth, increasing energy production, and boosting immunity.

公开(公告)号：US20220160620A1

公开(公告)日：2022-05-26

申请号：US17601463

申请日：2020-04-03

Applicant: Galia SALEH

Inventor： Galia SALEH

IPC: A61K9/00 ,  A61K36/8998 ,  A61K36/889 ,  A61K47/44 ,  A61K9/06 ,  A61K45/06

Abstract: Disclosed herein is a topical formulation for treating psoriasis. The formulation comprises ground wheat and a wheat extract, ground barley and a barley extract, an oil and egg or a fraction thereof. Also disclosed is a method for treating psoriasis comprising applying the topical formulation to an affected area of a patient.

公开(公告)号：US20200060975A1

公开(公告)日：2020-02-27

申请号：US16612653

申请日：2018-05-16

Applicant: DAICEL CORPORATION

Inventor： Mio MATSUOKA ,  Naohiro HASHIKAWA ,  Momoko HAMASAKI ,  Yoshihisa TAKIGAWA

IPC: A61K9/20 ,  A61K36/484 ,  A61K36/65 ,  A61K31/7008 ,  A61K31/7004 ,  A61K31/07 ,  A61K36/07 ,  A61K36/82 ,  A61K36/8998 ,  A61K36/31

Abstract: The purpose of the present invention is to provide various kinds of disintegrating tablets having various purposes and applications, such as for pharmaceuticals Chinese medicine and various kinds of foods and comprising various kinds of active ingredients such as the medicinal or nutritional ingredient, the supplement and the food component at a high concentration; and a composition for the disintegrating tablets.The present invention relates to a composition for a disintegrating tablet, comprising a disintegrator component consisting of only micro-fibrillated cellulose, and an active ingredient; and a disintegrating tablet for pharmaceuticals or foods, comprising the composition.

公开(公告)号：US20190201472A1

公开(公告)日：2019-07-04

申请号：US15859983

申请日：2018-01-02

Applicant: Chen-Yu LEE

Inventor： Chen-Yu LEE ,  Che-Hao WU ,  Yao-Nan YUAN ,  Chuang-Hsin CHIU ,  Yan-Chih LIAO ,  Yu-Ming FAN ,  Yuan-Hao CHEN ,  Dueng-Yuan HUENG

IPC: A61K36/8888 ,  A61K36/076 ,  A61K36/484 ,  A61K36/284 ,  A61K36/884 ,  A61K36/752 ,  A61K36/8998 ,  A61K36/9068 ,  A61K36/756 ,  A61K36/8988 ,  A61K36/714 ,  A61K36/232 ,  A61K36/481 ,  A61P25/16

CPC classification number: A61K36/8888 ,  A61K36/076 ,  A61K36/232 ,  A61K36/284 ,  A61K36/481 ,  A61K36/484 ,  A61K36/714 ,  A61K36/752 ,  A61K36/756 ,  A61K36/884 ,  A61K36/8988 ,  A61K36/8998 ,  A61K36/9068 ,  A61P25/16

Abstract: The present invention is directed to a therapeutic method of independent or adjuvant treatment of Parkinson's disease and Parkinson's syndrome, comprising administering to a subject in need a therapeutically effective amount of Chinese medicine composition, wherein the Chinese medicine composition comprises the extract of the mixture of Rhizoma Pinelliae, Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae, Rhizoma Atractylodis, Rhizoma Alismatis, Pericarpium Citri Reticulatae, Massa Medicata Fermentata, Fructus Hordei Germinatus, Rhizoma Zingiberis, Cortex Phellodendri, rhizoma Gastrodiae, Radix Aconiti Lateralis Praeparata, Radix Angelicae Sinensis, and Radix Astragali.

公开(公告)号：US20190192598A1

公开(公告)日：2019-06-27

申请号：US15967075

申请日：2018-04-30

Applicant: Zhonghua CI

Inventor： Zhonghua CI

IPC: A61K36/344 ,  A61K36/284 ,  A61K36/9066 ,  A61K36/8998 ,  A61K36/8994 ,  A61K36/9064 ,  A61K36/736 ,  A61K36/481 ,  A61K36/752 ,  A61K36/076 ,  A61K35/586 ,  A61K35/38 ,  A61K47/26 ,  A61K45/06 ,  A61K9/00

CPC classification number: A61K36/344 ,  A61K9/0053 ,  A61K35/38 ,  A61K35/586 ,  A61K36/076 ,  A61K36/284 ,  A61K36/481 ,  A61K36/736 ,  A61K36/752 ,  A61K36/8994 ,  A61K36/8998 ,  A61K36/9064 ,  A61K36/9066 ,  A61K45/06 ,  A61K47/26 ,  A61K2236/13 ,  A61K2236/51

Abstract: The present application discloses a Chinese herbal oral paste for conditioning phlegm-dampness constitution. The Chinese herbal oral paste includes the following raw material components: tangshen, prepared largehead atractylodes rhizome, prepared atractylodes rhizome, turmeric, unprocessed germinated barley, villous amomum fruit, coix seed, kelp, peach seed, tall gastrodia tuber, fuling, dried tangerine peel, seaweed, bitter apricot seed, cardamon fruit, perilla fruit, oriental waterplantain rhizome, ricepaperplant pith, Chinese waxgourd peel, kudzu vine root, unprocessed hawthorn fruit, milkvetch root, rice beans, lotus leaf, fortune eupatorium herb leaf, unprocessed cattail pollen, unprocessed rhubarb root and rhizome, inner membrane of chicken gizzard, white mustard seed, agastache rugosa, radish seed, xylitol, donkey-hide gelatin, and tortoise-plastron gelatin. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the phlegm-dampness constitution, will not create negative effects or harm to the human body at all, and is capable of achieving certain efficacy of strengthening physical health.

公开(公告)号：US09950024B2

公开(公告)日：2018-04-24

申请号：US15164844

申请日：2016-05-25

Applicant: INFINITUS (CHINA) COMPANY LTD.

Inventor： Shiyu Zou ,  Jiangping Li ,  Chung Wah Ma

IPC: A61K36/00 ,  A61K36/899 ,  A61K36/355 ,  A61K36/752 ,  A61K35/644 ,  A61K36/734 ,  A61K36/87 ,  A61K9/00 ,  A23L2/52 ,  A23L2/02 ,  A61K36/8998 ,  A61K47/26

CPC classification number: A61K36/899 ,  A23L2/02 ,  A23L2/52 ,  A23V2002/00 ,  A61K9/0095 ,  A61K35/644 ,  A61K36/355 ,  A61K36/734 ,  A61K36/752 ,  A61K36/87 ,  A61K36/8998 ,  A61K47/26 ,  A61K2300/00

Abstract: The present invention relates to the technical field of Traditional Chinese medicine, in particular to a traditional Chinese medicine composition and the use thereof. The traditional Chinese medicine composition comprises the following ingredients: honeysuckle, tangerine peel, stir-baked malt, honey, and hawthorn juice. The traditional Chinese medicine composition of the present invention has significant promotions on the gastric emptying rate, intestinal motility, gastric digestive enzyme (pepsin) activity and pancreatic enzyme (trypsin, chymotrypsin, amylase and lipase) activity of rats, exhibiting that the traditional Chinese medicine composition of the present invention has significant effects of clearing heat-fire and moistening the intestine.

公开(公告)号：US20180099001A1

公开(公告)日：2018-04-12

申请号：US15601497

申请日：2017-05-22

Applicant: VOLANT HOLDINGS GmbH

Inventor： Jerome Schentag ,  Joseph M. Fayad

IPC: A61K31/7004 ,  A61K9/28 ,  A61K31/00 ,  A61K9/20 ,  A61K36/05 ,  A61K31/555 ,  A61K36/48 ,  A61K35/741 ,  A61K36/8998 ,  A61K45/06 ,  A61K31/7056 ,  A61K31/7072 ,  A61K31/70 ,  A61K38/21

CPC classification number: A61K31/7004 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/282 ,  A61K9/2846 ,  A61K31/00 ,  A61K31/155 ,  A61K31/40 ,  A61K31/4985 ,  A61K31/555 ,  A61K31/70 ,  A61K31/7056 ,  A61K31/7072 ,  A61K35/741 ,  A61K36/05 ,  A61K36/48 ,  A61K36/8998 ,  A61K38/21 ,  A61K38/212 ,  A61K45/06 ,  A61K2300/00 ,  A61P1/16 ,  A61P31/14 ,  G01N33/6893 ,  G01N2800/085

Abstract: The present invention is directed to a System characterization of NASH that combines Modeling and Biomarkers, enabling pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steatohepatitis (NASH). Said conditions are Liver related complications among the array of manifestations of metabolic syndromes, including Type 2 diabetes, hyperlipidemia, weight gain, abdominal obesity, insulin resistance, hypertension, atherosclerosis, fatty liver diseases and certain chronic inflammatory states that lead to these manifestations, among others. In additional aspects, the present invention relates to compositions and methods which may be used to treat, inhibit or reduce the likelihood of NASH and NAFLD complications in patients with hepatitis viral infections, including Hepatitis B and Hepatitis C viral infections, as well as the secondary disease states and/or conditions which are often associated with such viral infections, including hepatic steatosis (steatohepatitis), cirrhosis, fatty liver and hepatocellular cancer, metabolic syndrome complications including cardiovascular diseases, neurodegenerative diseases and premature ageing, among other disease states or conditions.

公开(公告)号：US09808499B2

公开(公告)日：2017-11-07

申请号：US14547353

申请日：2014-11-19

Applicant: Kijoon Kim

Inventor： Kijoon Kim

IPC: A61K35/32 ,  A61K36/185 ,  A61K36/73 ,  A61K36/75 ,  A61K36/906 ,  A61K36/9068 ,  A61K36/72 ,  A61K36/28 ,  A61K36/42 ,  A61K36/481 ,  A61K36/534 ,  A61K36/538 ,  A61K36/734 ,  A61K36/752 ,  A61K36/8998 ,  A61K36/9064 ,  A61K36/284 ,  A61K36/725

CPC classification number: A61K36/9068 ,  A61K35/32 ,  A61K36/185 ,  A61K36/28 ,  A61K36/284 ,  A61K36/42 ,  A61K36/481 ,  A61K36/534 ,  A61K36/538 ,  A61K36/725 ,  A61K36/734 ,  A61K36/752 ,  A61K36/8998 ,  A61K36/9064 ,  A61K2236/00 ,  A61K2300/00

Abstract: The present invention relates to oriental medicine compositions marked as SEC 22 and SEC 33 for improving digestive functions and respiratory functions for improving children's underweight, low growth and depressed respiratory organ, an oriental medicine derived therefrom, and methods of preparing them. According to an example of the present invention, the oriental medicine composition containing broiled fruit of Crataegus pinnatifida, broiled root of Atractylodes japonica, dried peel of Citrus unshiu, broiled sprout of Hordeum vulgare, broiled fruit of Amomum xanthioides, root of Zingiber officinale, dried fruit of Zizyphi, and horn of Cervus elaphus.